Antibody-Drug Conjugate Gets FDA Thumbs Up for Untreated DLBCL
The FDA approved the…
Read More...
Read More...
Browsing Tag
Conjugate
Ractigen Therapeutics Receives FDA Orphan Drug Designation for the novel oligonucleotide conjugate…
<!-- Name:DistributionId Value:8781126 -->
<!--…
Read More...
Read More...
Antibody Drug Conjugate Market Size Worth USD 6.81 Billion by 2030 at 16.70% CAGR – Report by Market…
<!-- Name:DistributionId Value:8777422 -->
<!--…
Read More...
Read More...
Vaxcyte Reports Positive Topline Data from Phase 1/2 Proof-of-Concept Study of its 24-Valent…
-- In the Study, VAX-24 Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20™ (PCV20) at All Doses…
Read More...
Read More...
Antibody-Drug Conjugate Prolongs Survival in Metastatic Breast Cancer
PARIS -- Patients with heavily pretreated metastatic…
Read More...
Read More...
Antibody Drug Conjugate Market, a $13.15 billion Industry by 2030 with a CAGR of 14.12 %
New York, United States, June 21, 2022 (GLOBE NEWSWIRE) -- The surge in the antibody-drug conjugates market growth is…
Read More...
Read More...
Antibody-Drug Conjugate Promising for Breast Cancer With Brain Mets
The antibody-drug conjugate trastuzumab-deruxtecan (T-DXd;…
Read More...
Read More...
Global Cancer Antibody Drug Conjugate Market 2028
Delhi, April 08, 2022 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugate Market 2028 Report Highlights:…
Read More...
Read More...
Cancer Antibody Drug Conjugate Market 2028
Delhi, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugate Market, Drug Sales, Price, &…
Read More...
Read More...